Hyderabad: Despite a notice issued by the Drug Controller General of India on September 11, the state government has to yet form a committee to track patients who have undergone hip implant surgery, using implants marketed and imported by Johnson and Johnson which were found to be faulty.
The acetabular surface replacement (ASR) hip implants were imported and marketed between 2006 and 2010.
A Central committee has been formed at the Centre but the states have to issue notices so that aggrieved patients are identified and compensated.
The quantum of compensation to victims will be finalised after the documents are submitted to the state level committee and verified to ascertain whether they were from the set of faulty implants as declared by the United States Food and Drug Administration.
According to the notice of the Union health ministry, the faulty implants could result in disability as the metallic implant could have leaked toxic cobalt and chromium into patients’ bodies.
